Ontario Advancing Homegrown Research and Innovation

The Ontario government is investing nearly $200 million over the next three years to help advance Ontario-made research and innovation at six leading research institutes. This funding will help keep ideas, expertise and intellectual property in the province and support long-term economic growth.

“The Ontario government is proud to support homegrown research and innovation at Clinical Trials Ontario,” said Jill Dunlop, Minister of Colleges and Universities. “This funding is helping researchers solve some of the biggest challenges of our time that are making a very real difference to the lives of Ontarians.”

This investment includes $4 million over two years for Clinical Trials Ontario, a leading non-profit organization in the clinical trials community dedicated to strengthening, promoting and capitalizing on Ontario’s competitive advantages for conducting high-quality clinical trials.

“Clinical trials play a vital role in advancing healthcare and bringing new therapies to Ontarians. At Clinical Trials Ontario, we collaborate with researchers, patients, industryinstitutions, and others to support the conduct of high-quality clinical trials that are timely, cost-effective and accessible. We thank the Government of Ontario for its continued support in fueling a thriving clinical trials sector that will bring more talent and trial opportunities to the province, and drive innovation in medicine.” – Susan Marlin, President and CEO, Clinical Trials Ontario

Read the full news release from the Ministry of Colleges and Universities here.

More CTO Stories